Advancing genomic discoveries in neurodegenerative diseases

Neuro Array Consortium

The Neuro Consortium was a collaboration with researchers in the neurogenomics community. The consortium contributed content in a high-density neuro-targeted array for investigation of neurodegenerative diseases. This array combines a genome-wide backbone with over 180K expertly selected, easily accessible neurodegenerative disease markers.

The Neuro Consortium Array offers a rapid, cost-effective, high-throughput genotyping solution for fine mapping and replication of previously identified genetic variants associated with common neurodegenerative diseases. The neurodegenerative content is modular and portable as an add-on, focused content set to selected Illumina genome-wide backbone arrays.

Neuro Array Consortium Video
Neuro Consortium Array Review

Learn how the Neuro Consortium Array enables understanding of the genetic basis of neurodegenerative diseases.

The Infinium Neuro Consortium Array is now available as a consortium product.
Add custom Infinium Neuro Consortium Array content to the following array products:

Experts in different disease areas carefully identified markers found in known neurodegenerative disease genes. The consortium based marker selection on extensive literature review, validated research results, and in-depth database search. Content includes specific focus on the following diseases.

  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Amyotrophic Lateral Sclerosis
  • Multiple Sclerosis
  • Progressive Supranuclear Palsy/Corticobasal Degeneration
  • Multiple System Atrophy
  • Frontotemporal Dementia
  • Dementia with Lewy Bodies
Interested in receiving newsletters, case studies, and information on human consortia? Enter your email address.